HEMEX

AI has the potential to transform drug development, particularly by enhancing the speed and efficiency of clinical trials. In the early phases of study planning, AI can optimize trial design, predict obstacles, and improve patient and site selection. 📄Study Design: AI can rapidly analyze vast datasets, including historical trial data, medical literature, and real-world evidence, to design more effective studies with optimized trial endpoints. 🗺️Patient Selection: AI algorithms can analyze electronic health records (EHRs), genetic data, and patient demographics to identify the most suitable candidates for a trial. 🏥Site Selection: AI-driven site optimization tools can predict which clinical trial sites will recruit patients more effectively based on historical performance, geographic patient density, and regional healthcare infrastructure. One critical role of CROs in this context is the regulatory compliance for AI, which enables the secure and compliant use of AI/ML tools in regulated healthcare while advancing innovation. An example of the application of AI in clinical trials is the recently launched Synthetic hEalthcare dAta goveRnanCe Hub (SEARCH) initiative. As part of this initiative, HEMEX contributes to the project by leading the regulatory compliance efforts for AI, ensuring adherence to all relevant legal standards. ⁉️ Are you looking for excellence in a CRO Contact us! 📞💻 ____________________________________________________________________ Leading clinical trials with detail, efficiency, and excellence ♾️Share if others could benefit from this too! 🔔 To follow Hemex click the bell on the profile. #CRO #ClinicalTrials #AIinClinicalTrials #TrialDesign #FasterTrials

The pharmaceutical and biotech industries require flexibility and prompt attention to efficiently navigate clinical trials. At Hemex, we are fully equipped to assist you at every stage of the process. We are dedicated to providing prompt responses to changing circumstances while prioritizing smaller projects. By cultivating robust partnerships with sites and advocating for our sponsors, we ensure a collaborative and supportive process throughout the entire project lifecycle. With offices located throughout various European countries, we can offer: Study Start-up Regulatory Submission Clinical Study Management Clinical Monitoring Reach out to us to discover how we can support your projects effectively. Learn more at: https://hemex.ch/pharma/ ⁉️ Are you looking for excellence in a CRO Contact us! 📞💻 ____________________________________________________________________ Leading clinical trials with detail, efficiency, and excellence ♾️Share if others could benefit from this too! 🔔 To follow Hemex click the bell on the profile. #CRO #Clinicaltrials #Pharma #Biotech #Pharmacovigilance #RegulatoryAffairs #ClinicalMonitoring #ClinicalAudit #StudyManagement

Let’s take a moment to raise awareness about Alzheimer’s disease—a condition that affects millions of people worldwide and accounts for 60-80% of dementia cases. It’s a progressive disease—starting with mild memory loss and worsening over time, eventually affecting language, problem-solving, and even daily tasks. Although, there is currently no cure for Alzheimer’s, there are treatments and lifestyle changes that can help manage symptoms and improve quality of life. Risk? ⚠️ Age: The risk increases significantly after age 65. ⚠️Family History: Those with a parent or sibling with Alzheimer’s are more likely to develop the disease. ⚠️Lifestyle & Health Factors: Conditions like heart disease, diabetes, and high blood pressure can increase risk. Preventing Alzheimer’s disease is a complex area of research, and while there is no guaranteed way to prevent the condition, several strategies may help reduce the risk or delay the onset: ✅ Maintain a healthy diet ✅ Stay physically Active ✅ Enate in mental stimulation ✅ Get quality sleep By incorporating these preventive measures into daily life, individuals can contribute to their overall brain health and potentially lower their risk of developing Alzheimer’s disease. Early intervention and lifestyle modifications can be vital in managing risk factors and promoting cognitive wellness. Learn more about Alzheimer’s and dementia: https://lnkd.in/eRKXcbZ @bottneuro ⁉️ Are you looking for excellence in a CRO Contact us! 📞💻 ____________________________________________________________________ Leading clinical trials with detail, efficiency, and excellence ♾️Share if others could benefit from this too! 🔔 To follow Hemex click the bell on the profile. #AlzheimersAwareness #AlzheimersPrevention #CRO #Clinicaltrials

Historically, minority populations have been underrepresented in clinical research, resulting in treatments that may not address the safety and efficacy needs of all demographic groups. This gap offers MedTech companies a significant opportunity to incorporate diversity, equity, and inclusion (DEI) into clinical trial recruitment, providing a competitive advantage in key areas: Ethnicity is not directly a factor in medical devices, but including diverse populations in clinical trials is important for several reasons. Device Performance: Variations in anatomy and physiology affect device performance, making diverse trials essential for identifying potential issues. Usability: Cultural attitudes toward technology influence acceptance. Engaging diverse populations can enhance device usability and patient acceptance. While integrating diversity in clinical trials may entail higher initial costs due to broader recruitment and complex trial design, these investments could yield long-term financial returns. More effective treatments for diverse populations can help companies capture larger market shares and minimize costly post-market issues. ⁉️ Are you looking for excellence in a CRO Contact us! 📞💻 ____________________________________________________________________ Leading clinical trials with detail, efficiency, and excellence ♾️Share if others could benefit from this too! 🔔 To follow Hemex click the bell on the profile. #ClinicalTrials #DiversityInHealthcare #DEI #MedTech #CRO

🌟 Had a wonderful time last night at the networking dinner hosted by BSI Life Sciences at Die Giesserei! ✨A big thank you to BSI Life Sciences for the invitation and for creating such a relaxed and engaging setting where I could connect with other #CTMS clients and make new connections. Events like these are invaluable for building relationships and sharing insights with industry colleagues. Looking forward to future collaborations and continuing the conversations! 🤝🍽️ #Networking #BSI #CTMS #Clinicaltrials #eTMF Jan Klint Nielsen Simon Rissi Hafeezul Adnan

At Hemex we don’t have lunch breaks... ... we have a time where our team comes together to share, learn, and laugh! With colleagues from diverse cultural backgrounds, our conversations are rich and varied, spanning across different topics and experiences. From exchanging favourite cooking recipes 🍲, to sharing interesting jokes that keep us laughing 😂, to unique experiences while traveling, to unexpected stories of how Switzerland was in the past — our lunchtime talks allow us to grow as a team and broaden our horizons. These moments help us connect on a personal level, fostering a sense of unity and understanding that strengthens both our work and relationships. Here's to the power of diversity and learning through shared experiences! ⁉️ Are you looking for excellence in a CRO Contact us! 📞💻 ____________________________________________________________________ Leading clinical trials with detail, efficiency, and excellence ♾️Share if others could benefit from this too! 🔔 To follow Hemex click the bell on the profile. #TeamCulture #DiversityInTheWorkplace #CRO #Clinicaltrials

Don't miss tomorrow's free webinar on the key changes to ICH GCP E6 Revision 3. We will discuss how these changes impact the oversight requirements of service providers for Sponsors. We will also discuss the downstream impact on Clinical Trial Service Providers and how working relationships with Sponsors might be adjusted. The webinar will be presented by: Tom Lazenby Founder & CEO - Mayet, Vendor Management in Clinical Trials WHEN: Tomorrow, 22nd October, 2024 TIME: 2:00 PM (CET) REGISTER NOW HERE: https://lnkd.in/ePNpDd66 See you there! ⁉️ Are you looking for excellence in a CRO Contact us! 📞💻 ____________________________________________________________________ Leading clinical trials with detail, efficiency, and excellence ♾️Share if others could benefit from this too! 🔔 To follow Hemex click the bell on the profile. #GCP #ICHGCP #VendorManagement #CRO #ClinicalTrials

🔬Medical devices in risk classes 2a and 3 require robust clinical evidence to ensure safety and efficacy. These high-risk devices, often life-saving, must undergo rigorous clinical trials to meet regulatory standards. Conducting such trials can be complex, demanding precise planning, comprehensive knowledge of medical regulations, and seamless coordination between stakeholders. At HEMEX, we specialise in the management of clinical trials for these critical devices. ✅ Every device is unique. We work closely with you to design trials that suit your product’s specific needs, ensuring efficient data collection, patient safety, and accurate results. ✅ From feasibility analysis and site selection to patient recruitment and data management, we handle all phases of the clinical trial, allowing you to focus on innovation. 💡 Are you looking to advance your medical device to the next level? Let's explore how HEMEX can assist with your clinical trials. Learn more at: https://hemex.ch/medtech/ ⁉️ Are you looking for excellence in a CRO Contact us! 📞💻 ____________________________________________________________________ Leading clinical trials with detail, efficiency, and excellence ♾️Share if others could benefit from this too! 🔔 To follow Hemex click the bell on the profile. #MedTech #MentalHealthMatters #CRO #Clinicaltrials #MedicalDevices #QMS #ClinicalTrialManagement

✨ HEMEX Benelux BV a Hemex AG subsidiary is part of the innovative Synthetic hEalthcare dAta goveRnanCe Hub (SEARCH) initiative, recently launched by Trinity College Dublin. HEMEX contributes to the project by leading the regulatory compliance efforts for AI, ensuring adherence to all relevant legal standards. Hemex role involves managing communication with regulatory bodies to guarantee that synthetic data used in AI applications complies with regulations governing healthcare data privacy, AI technologies, and patient protection. This role is critical for enabling the secure and compliant use of AI/ML tools in regulated healthcare while advancing innovation. 🔗 Read the full press release here: https://lnkd.in/e8Wak6jZ This SEARCH project is supported by the Innovative Health Initiative (IHI) Joint Undertaking (IHI JU) under grant agreement No. 101172997. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA - European Federation of Pharmaceutical Industries and Associations (including Vaccines Europe), EuropaBio - the European Association for Bioindustries and MedTech Europe. ⁉️ Are you looking for excellence in a CRO Contact us! 📞💻 ____________________________________________________________________ Leading clinical trials with detail, efficiency, and excellence ♾️Share if others could benefit from this too! 🔔 To follow Hemex click the bell on the profile. #Healthcare #CRO #Clinicaltrials #SecureData #HealthTech #SyntheticData #IHISEARCH #FederatedLearning

Obesity is a major public health challenge affecting millions worldwide and leading to conditions like diabetes, heart disease, and certain cancers. Despite the benefits of diet and exercise, many struggle with weight management due to genetics, metabolism, and environment. Fortunately, new medications like semaglutide (Wegovy) and tirzepatide (Mounjaro) help patients lose 15-20% of their body weight.* These drugs also improve related conditions, such as hypertension and type 2 diabetes, reducing the risk of chronic diseases. The involvement of a Contract Research Organization (CRO) is vital for the execution of clinical trials. It serves as an independent entity that provides specialized support in managing the complexities of the trial process, from protocol development to data management. * https://lnkd.in/eUPpx63i ⁉️ Are you looking for excellence in a CRO Contact us! 📞💻 ____________________________________________________________________ Leading clinical trials with detail, efficiency, and excellence ♾️Share if others could benefit from this too! 🔔 To follow Hemex click the bell on the profile. #Obesity #HealthcareInnovation #CRO #ClinicalTrials